We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+3.1%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$3.7B
AUM Growth
+$36.9M
Cap. Flow
-$52.6M
Cap. Flow %
-1.42%
Top 10 Hldgs %
32.88%
Holding
660
New
37
Increased
95
Reduced
157
Closed
37

Top Sells

Rank Stock Value
1
LLTC
Linear Technology Corp
LLTC
+$28.7M
2
ABB
ABB Ltd
ABB
+$22.8M
3
PG icon
Procter & Gamble
PG
+$9.45M
4
MCD icon
McDonald's
MCD
+$7.37M
5
EOG icon
EOG Resources
EOG
+$6.06M

Sector Composition

Rank Sector Weight
1 Technology 23.37%
2 Healthcare 14.81%
3 Consumer Staples 14.51%
4 Industrials 13.6%
5 Consumer Discretionary 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRP icon
351
TC Energy
TRP
$65.9B
$107K ﹤0.01%
2,250
DTV
352
DELISTED
DIRECTV COM STK (DE)
DTV
$107K ﹤0.01%
1,257
-3,625
-74% -$295K
ANSS
353
DELISTED
Ansys
ANSS
$106K ﹤0.01%
1,400
PAA icon
354
Plains All American Pipeline
PAA
$16.4B
$104K ﹤0.01%
1,724
+1,300
+307% +$74K
WSO icon
355
Watsco Inc
WSO
$12.9B
$103K ﹤0.01%
1,000
CVA
356
DELISTED
Covanta Holding Corporation
CVA
$103K ﹤0.01%
5,000
ULTI
357
DELISTED
Ultimate Software Group Inc
ULTI
$103K ﹤0.01%
745
POOL icon
358
Pool Corp
POOL
$7.23B
$102K ﹤0.01%
1,800
ITRI icon
359
Itron
ITRI
$4.41B
$101K ﹤0.01%
2,500
-9,035
-78% -$344K
VSS icon
360
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$12B
$100K ﹤0.01%
900
TEVA icon
361
Teva Pharmaceuticals
TEVA
$42.9B
$97K ﹤0.01%
1,850
-8,215
-82% -$420K
AMP icon
362
Ameriprise Financial
AMP
$49.7B
$96K ﹤0.01%
800
AER icon
363
AerCap
AER
$23.5B
$94K ﹤0.01%
2,045
VEU icon
364
Vanguard FTSE All-World ex-US ETF
VEU
$70.7B
$94K ﹤0.01%
1,800
VTRS icon
365
Viatris
VTRS
$18.7B
$94K ﹤0.01%
1,825
TVTY
366
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$94K ﹤0.01%
5,380
RMD icon
367
ResMed
RMD
$32.7B
$91K ﹤0.01%
1,800
WIN
368
DELISTED
Windstream Holdings Inc
WIN
$90K ﹤0.01%
1,149
STJ
369
DELISTED
St Jude Medical
STJ
$90K ﹤0.01%
+1,300
New +$84.3K
FLS icon
370
Flowserve
FLS
$10.1B
$89K ﹤0.01%
1,200
POR icon
371
Portland General Electric
POR
$5.93B
$89K ﹤0.01%
2,563
SLV icon
372
iShares Silver Trust
SLV
$31.5B
$89K ﹤0.01%
+4,400
New +$83.1K
DGRW icon
373
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.3B
$87K ﹤0.01%
3,000
SBR
374
Sabine Royalty Trust
SBR
$1.06B
$87K ﹤0.01%
1,437
KSU
375
DELISTED
Kansas City Southern
KSU
$87K ﹤0.01%
811
-1,025
-56% -$106K

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, Loring Wolcott & Coolidge Fiduciary Advisors held 660 positions worth $3.7B, up 1% from $3.66B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q2 2014 filing shows 37 new, 95 increased, 157 reduced and 37 closed positions. Its largest new stake was Pioneer Natural Resource Co.: 2,000 shares worth $460K. The largest sale was Linear Technology Corp, an estimated $28.7M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q2 2014 buy was Pioneer Natural Resource Co.: 2,000 shares worth $460K.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Celgene Corp in Q2 2014, an estimated $19.9M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q2 2014 reduction was Linear Technology Corp, cutting an estimated $28.7M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited CATAMARAN CORP COM STK (CDA) in Q2 2014, selling an estimated $98K.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 33% of its $3.7B portfolio in Q2 2014.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 37 new positions and closed 37 in Q2 2014.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 1% quarter-over-quarter to $3.7B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2014, filed 12 Aug 2014.